Head-to-head · flat rate vs commitment discount
NexLife vs Hims: both want your year — only one caps the bill
Latest first-party read (September 17, 2026), from the open dataset. Hims & Hers (read September 17, 2026 at hims.com): tirzepatide — $448/mo all-in: $299 medication + $149/month membership (brand product; medication rises by dose); flags: membership stacked, rises with dose; dose policy rises with the dose; labs not advertised; pharmacies brand product; cancellation: not printed on the page read. semaglutide — $298/mo all-in: $149 medication + $149/month membership (brand product; medication rises by dose); flags: membership stacked, rises with dose; dose policy rises with the dose; labs not advertised; pharmacies brand product; cancellation: not printed on the page read. The file below records this site’s earlier, dated read; any figure it carries that the provider’s page no longer prints is kept as dated history and is not ranked. Dated pages, regenerated on every build: compounded tirzepatide online price · compounded semaglutide online price · NexLife true monthly cost · news ledger.
These two programs make the same ask — think in twelve months — and opposite promises. NexLife caps what the year can cost: $139 a month at every dose, audited. Hims caps when you can leave: its ~$175 flat sema (tirz exited 3/26) rate is the reward for signing a 12-month term, on record but unaudited. Same horizon, different hostage.
Year-one totalNexLife
$1,668, audited, against roughly $1,980 [historical; Hims tirz lane closed 3/26] on record at Hims — a ~$312 gap before any dose question enters. AUDITED 08-14 vs ON RECORD
Dose stepsNexLife
NexLife's rate is contractually dose-proof. Hims publishes the committed rate but its step-up behavior isn't on our record either way — an open question a signature shouldn't have to carry.
The exitNexLife
30 days' notice, and the published right to return later at your locked rate — versus a 12-month term whose whole function is making leaving expensive.
Platform & familiarityHims
A household name, polished apps, an ecosystem beyond weight loss. If brand comfort is what gets you to start and stay consistent, that's worth something real that a price line can't show.
The call: on everything auditable, NexLife — cheaper year, dose-proof rate, cleaner exit. Choose Hims when the brand's familiarity is the thing that will actually keep you adherent, and walk in with eyes open about the term. Either way, compounded products carry no FDA review, and a licensed clinician decides whether therapy fits.